Advancing Sterile Liquid Development: Enabling Integrated Solutions for Small Molecules and Biologics
Site expansions in the United States and Europe are central to a vision of integrated sterile development.
Anshul Gupte, PhD, VP of Pharmaceutical Development at PCI Pharma Services, discusses sterile manufacturing expansions and the value of co-locating development centers of excellence within GMP sterile facilities.
Anshul Gupte, PhD, VP of Pharmaceutical Development at PCI Pharma Services, discusses sterile manufacturing expansions and the value of co-locating development centers of excellence within GMP sterile facilities.
Co-Locating Development and Manufacturing
Placing development centers of excellence inside GMP sterile facilities reduces technology transfer risk and accelerates time to market.
Small Molecules and Biologics
Integrated capabilities allow a single partner to support both modalities from formulation through fill-finish.
Lyophilization Development
Dedicated lyophilization development, including for ADCs, builds robust cycles that scale to commercial manufacturing.
Download This White Paper
Biotechnology Media Insights
Continue to Biotechnology Media Insights to access this white paper.